Evidence map›Paper›PMID 42053695›Full record

ArticleCEN case reports2026

Acute esophageal necrosis in end-stage renal disease.

Satoshi Ototake, Isao Aoyama

Abstract readCase Reports
In one paragraph

Article in CEN case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Satoshi OtotakeDepartment of Renal Replacement Therapy, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, Japan. satoshiototake@gmail.com.ORCID 0009-0004-7974-9360
Isao AoyamaDepartment of Nephrology, Japan Community Health Care Organization Chukyo Hospital, Nagoya, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute esophageal necrosis is a rare but often fatal condition characterized by diffuse black discoloration of the esophageal mucosa. While commonly associated with hemodynamic compromise, or infection, the pathogenesis is often multifactorial. We report a fatal case of acute esophageal necrosis in a man in his 50s with untreated long-standing hypertension and newly diagnosed end-stage renal disease. The patient presented with fatigue, loss of appetite, and respiratory distress and was admitted with pneumonia, pulmonary edema, and advanced renal dysfunction. After the initiation of hemodialysis, the patient’s oxygenation status and loss of appetite improved, allowing the resumption of oral intake on day 5. Despite temporary improvement, the patient occasionally complained of chest discomfort. Although we ruled out cardiac disease, diseases of the upper gastrointestinal tract were not considered in the differential diagnosis. On day 10, due to melena and worsening anemia, an urgent upper gastrointestinal endoscopy was performed, revealing acute esophageal necrosis. At that moment, we suddenly realized that the chest discomfort was especially noticeable after meals and caused by acute esophageal necrosis. We continued supportive therapy, but the patient unfortunately passed away. Autopsy revealed acute necrotizing esophagitis with Candida albicans, end-stage renal disease from untreated hypertension, pulmonary edema, and pneumonia. This case provides valuable insight for nephrologists, emphasizing the need to consider this rare but fatal disease in the differential diagnosis of patients presenting with chest discomfort.

Indexed as

EsophagitisEsophagusKidney Failure, ChronicAcute DiseaseCandidiasisDiagnosis, DifferentialFatal OutcomeHumansMaleMiddle AgedNecrosisRenal DialysisAcute esophageal necrosisCase reportEnd-stage renal disease

Identifiers

PMID42053695
PMCPMC13129171

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.